fbpx Skip to main content

Member's Profile

Eidos Therapeutics

Location
101 MONTGOMERY STREET, SUITE 2000
San Francisco,   CA
94104
United States
Sector
Biotech
Membership Info
Membership Type: Industry
Membership Since: 2018
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About Eidos Therapeutics
Biotech Company

Eidos Therapeutics is a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. We seek to treat this well-defined family of diseases at their collective source by stabilizing TTR. Our product candidate, AG10, an orally-administered small molecule designed to potently stabilize TTR, is a potentially best-in-class treatment aiming to halt the progression of ATTR diseases.

Founded in 2013, Eidos is led by a team of industry veterans who are responsible for developing over 30 molecules through IND applications and more than 10 approved drugs. Together with patients and physicians, we aim to bring a safe,…

Related News
No related news posted by this Member